Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

This protocol outlines experimental procedures to characterize genome-wide changes in the levels of histone post-translational modifications (PTM) occurring in connection with the overexpression of proteins associated with ALS and Parkinson's disease in Saccharomyces cerevisiae models. After SDS-PAGE separation, individual histone PTM levels are detected with modification-specific antibodies via Western blotting.

Abstract

Neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD), cause the loss of hundreds of thousands of lives each year. Effective treatment options able to halt disease progression are lacking. Despite the extensive sequencing efforts in large patient populations, the majority of ALS and PD cases remain unexplained by genetic mutations alone. Epigenetics mechanisms, such as the post-translational modification of histone proteins, may be involved in neurodegenerative disease etiology and progression and lead to new targets for pharmaceutical intervention. Mammalian in vivo and in vitro models of ALS and PD are costly and often require prolonged and laborious experimental protocols. Here, we outline a practical, fast, and cost-effective approach to determining genome-wide alterations in histone modification levels using Saccharomyces cerevisiae as a model system. This protocol allows for comprehensive investigations into epigenetic changes connected to neurodegenerative proteinopathies that corroborate previous findings in different model systems while significantly expanding our knowledge of the neurodegenerative disease epigenome.

Introduction

Neurodegenerative diseases are devastating illnesses with little to no treatment options available. Among these, amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD) are particularly dreadful. Approximately 90% of ALS and PD cases are considered sporadic, occurring without family history of the disease, while the remaining cases run in families and are generally linked to a specific gene mutation1,2. Interestingly, both of these diseases are associated with protein mislocalization and aggregation3,4,5<....

Protocol

1. Transforming S. cerevisiae with neurodegenerative proteinopathy-associated protein constructs

  1. Grow wild type (WT) 303 yeast in yeast extract peptone dextrose (YPD) broth overnight with shaking (200 rpm) at 30 °C.
  2. After 12−16 h of growth, dilute yeast to an optical density at 600 nm (OD600) of 0.25 with YPD. As 10 mL of yeast liquid culture will be needed for each transformation, prepare 50 mL of yeast liquid culture for five transformations corresponding to FUS, TDP.......

Representative Results

To illustrate this method, we will take advantage of recently published results30. WT human FUS and TDP-43 were overexpressed for 5 h, while WT α-synuclein was overexpressed for 8 h. A ccdB construct was used as a vector negative control. Figure 2 shows growth suppression in solid and liquid cultures. Yeast was harvested as described and Western blotting with modification-specific antibodies was performed. Anti-total H3 was used a.......

Discussion

The protocol described here provides a straightforward, expedient, and cost-effective way of categorizing genome-wide histone PTM changes correlated with neurodegenerative proteinopathies. While there are other models of ALS and PD, such as in vitro human cell lines and murine models32, S. cerevisiae remains attractive because of its ease of use. For instance, yeast models do not require use of a sterile hood, nor do they require the intensive training that goes along with cell c.......

Acknowledgements

We thank Royena Tanaz, Huda Yousuf, and Sadiqa Taasen for technical help. We are very grateful to Prof. James Shorter for the generous provision of reagents and intellectual assistance in the design of sucrose tuning experiments. Yeast plasmids were a generous gift from Prof. Aaron Gitler (including 303Gal-FUS; Addgene plasmid # 29614). Brooklyn College and the Advanced Science Research Center (CUNY) as well as an NIH NINDS Advanced Postdoctoral Transition Award (K22NS09131401) supported M.P.T.

....

Materials

NameCompanyCatalog NumberComments
-His DO SupplementClontech630415
10x Running BufferMix: 141.65 g glycine (ThermoFisher BP381-1), 30.3 g Tizma base (Sigma-Aldrich T6066), 10 g sodium dodecyl sulfate (Sigma-Aldrich L3771), and 1 L deionized water, pH 8.8.
12% Polyacrylamide GelsBIO-RAD456-1041
2-mercaptoethanolSigma-AldrichM3148
Anti-acetyl-Histone H3 (Lys14) Primary AntibodyMilliporeSigma07-353 (Lot No. 2762291)Dilution: 1/1000
Anti-acetyl-Histone H4 (Lys 16) Primary AntibodyAbcamab109463 (Lot No. GR187780)Dilution: 1/2000
Anti-acetyl-Histone H4 (Lys12) Primary AntibodyAbcamab46983 (Lot No. GR71882)Dilution: 1/5000
Anti-dimethyl-Histone H3 (Lys36) Primary AntibodyAbcamab9049 (Lot No. GR266894, GR3236147)Dilution: 1/1000
Anti-Histone H3 Primary AntibodyAbcamab24834 (Lot No. GR236539, GR174196, GR3194335)Nuclear Loading Control; Dilution: 1/2000
Anti-phospho-Histone H2B (Thr129) Primary AntibodyAbcamab188292 (Lot No. GR211874)Dilution: 1/1000
Anti-phospho-Histone H3 (Ser10) Primary AntibodyAbcamab5176 (Lot No. GR264582, GR192662, GR3217296)Dilution: 1/1000
BioPhotometer D30Eppendorf6133000010
Cell Culture Dish (100 x 20 mm)Eppendorf30702118
Cell Culture Plate, 96 wellEppendorf30730011
Centrifuge 5804/5804 R/5810/5810 REppendorf22625501
Donkey Anti-Mouse IRDye 800 CWLI-COR926-32212 (Lot No. C60301-05, C61116-02, C80108-05)Dilution: 1/5000
Donkey Anti-Rabbit IRDye 860 RDLI-COR926-68073 (Lot No. C60217-06, C70323-06, C70601-05, C80116-07)Dilution: 1/2500
EthanolSigma-AldrichE7023
Extra thick blot paper (filter paper)BIO-RAD1703968
GalactoseSigma-AldrichG0750Prepare 20% w/v stock solution.
GlucoseSigma-AldrichG8270Prepare 20% w/v stock solution.
GlycerolSigma-AldrichG5516Prepare 50 % w/v solution.
Immobilon-FL Transfer MembranesMilliporeSigmaIPFL00010
Lithium acetate dihydrate (LiAc)Sigma-AldrichL4158Prepare a 1 M solution.
Loading DyeMix: 1.2 g sodium dodecyl sulfate, 6 mg bromophenol blue (Sigma-Aldrich B8026), 4.7 mL glycerol, 1.2 mL 0.5M Trizma base pH 6.8, 0.93 g DL-Dithiothreitol (Sigma-Aldrich D0632), and 2.1 mL deionized water.
MethanolThermoFisherA412-4
Mini-PROTEAN Tetra Vertical Electrophoeresis CellBIO-RAD1658004
Multichannel pipetEppendorf2231300045
NEB Restriction Enzyme Buffer 2.1, 10xNew England Bio Labs102855-152
Nhe I Restriction EnzymeNew England Bio Labs101228-710
Nuclease Free WaterQiagen129114
Odyssey Fc Imaging SystemLI-COR Biosciences2800-03
OmniTray Cell Culture Treated w/Lid Sterile, PS (86 x 128 mm)ThermoFisher165218
pAG303GAL-a-synuclein-GFPGift from A. Gitler
pAG303GAL-ccdBAddgene14133
pAG303Gal-FUSAddgene29614
pAG303GAL-TDP-43Gift from A. Gitler
Poly(ethylene glycol) (PEG)Sigma-AldrichP4338Prepare a 50% w/v solution.
Ponceau S StainSigma-AldrichP3504Mix: 0.5 g 0.1% w/w Ponceau S dye, 5 mL 1% v/v acetic acid (Sigma-Aldrich 320099), and 500 mL deionized water.
PowerPac Basic Power SupplyBIO-RAD164-5050
Raffinose pentahydrateSigma-AldrichR7630Prepare 10% w/v stock solution.
Salmon Sperm DNAAgilent Tech201190
SD-His platesMix: 20 g Agar (Sigma-Aldrich A1296), 0.77 g -His DO supplement, 6.7 g yeast Nitrogen Base w/o amino acids (ThermoFisher 291920), and 900 mL deionized water.
SGal-His platesMix: 20 g Agar, 0.77 g -His DO supplement, 6.7 g yeast Nitrogen Base w/o amino acids, 100 mL galactose solution, and 900 mL deionized water.
Sodium dodecyl sulfate Loading BufferStore at -20 oC. 6X, Mix: 1.2 g sodium dodecyl sulfate, 6 mg bromophenol blue, 0.93 g DL-Dithiothreitol, 2.1 mL deionized water, 4.7 mL glycerol, and 1.2 mL 0.5 M Trizma base, pH 6.8.
Sodium hydroxideSigma-Aldrich221465Prepare 0.2 M solution.
SucroseSigma-Aldrich84097Prepare 20% w/v stock solution.
TBS + 0.1% Tween 20 (TBST)Mix: 100 mL 10X TBS, 1 mL Tween 20 (Sigma-Aldrich P7949), and 900 mL deionized water.
TBS Blocking BufferLI-COR927-5000
Trans-Blot SD Semi-Dry Electrophoretic Transfer CellBIO-RAD170-3940
Transfer BufferMix: 22.5 g glycine, 4.84 g Tizma base, 400 mL methanol, 1 g sodium dodecyl sulfate, and 1.6 L deionized water.
Tris-Buffered Saline (TBS)10X, 7.6 pH, Solution: Mix 24 g Trizma base, and 88 g sodium chloride (Sigma-Aldrich S7653). Fill to 1 L with deionized water.
WT 303 S. cerevisiae yeastGift from J. Shorter
Yeast Extract Peptone Dextrose (YPD)Sigma-AldrichY1375

References

  1. Landgrave-Gómez, J., Mercado-Gómez, O., Guevara-Guzmán, R. Epigenetic mechanisms in neurological and neurodegenerative diseases. Frontiers in Cellular Neuroscience. 9, 58 (2015).
  2. Paez-Colasante, X., Figueroa-Romero, C., Sakowski, S. A., Goutman, S. A., Feldman, E. L.

Explore More Articles

HistonePost translational ModificationYeastNeurodegenerative ProteinopathyEpigeneticsNeurodegenerative DiseaseFibroblastsInduced Pluripotent Stem CellsWestern BlotYeast CultureProtein OverexpressionOptical DensityCell HarvestingCell Lysis

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved